On September 24, 2012, Response Biomedical Corp. (the "Company"), announced by press release the completion of the consolidation of issued and outstanding common shares of the Company (the "Common Shares") at a ratio of one (1) post-consolidation Common Share for every twenty (20) pre-consolidation Common Shares (the "Consolidation"). The Consolidation was approved by the Company's shareholders on June 19, 2012. The Company's Common Shares will continue to be traded on the Toronto Stock Exchange under the symbol "RBM" and on the OTC Bulletin Board in the United States under the symbol "RPBIF". Trading will commence on a post-consolidation basis under a new CUSIP on or about September 26, 2012. No fractional Common Shares will be issued pursuant to the Consolidation and shareholders will not receive cash in lieu of fractional Common Shares resulting from the Consolidation.

(d) Exhibits.

Exhibit Number                        Description
     99.1        Press release of Response Biomedical Corp. dated
                 September 24, 2012